贫血治疗市场 - 增长、趋势和预测(2022 - 2027 年)

贫血治疗市场按疾病类型(缺铁性贫血、慢性肾病贫血、镰状细胞性贫血、再生障碍性贫血等)和地理划分

市场快照

Anemia Treatment Market Size
Study Period: 2017-2025
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.3 %
Anemia Treatment Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计贫血治疗市场在预测期内将出现强劲增长,这主要归因于全球贫血病例的增加、贫血药物的管道增加以及育龄妇女人数的增加。

美国国立卫生研究院表示,贫血影响世界约三分之一的人口,并导致发病率和死亡率增加、工作效率下降和神经发育受损。较易患此病的人群是5岁以下的儿童和孕妇。正在努力减轻这种疾病的负担。例如,世界卫生组织关于贫血的 2025 年全球营养目标旨在到 2025 年将 WRA 的贫血减少 50%。因此,通过这些努力,接受治疗的人数将会增加,最终市场将会增长。

报告范围

贫血是一个人缺乏足够的健康红细胞来将足够的氧气输送到身体组织的情况。

By Type of Disease
Iron Deficiency Anemia
CKD (Chronic Kidney Disease) Anemia
Sickle Cell Anemia
Aplastic Anemia
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

缺铁性贫血在预测期内见证健康的复合年增长率

缺铁性贫血是最常见的贫血类型,其中血液中没有足够量的 reb 血细胞,这些血细胞将氧气输送到身体组织。根据美国国立卫生研究院的说法,缺铁性贫血是影响大部分人口的主要营养缺乏症之一,特别是儿童、经期妇女和孕妇等生理群体。

同样,在印度和中国等亚洲国家,缺铁性贫血正在给女性带来越来越多的疾病负担。因此,相信该细分市场将在预测期内实现健康增长。

Anemia Treatment Market Share

北美主导市场

北美主导了整个贫血治疗市场,美国是该市场的主要贡献者。2018年衰老与发育机制研究显示,缺铁性贫血在孕妇和儿童中高发。在美国,育龄妇女的缺铁性贫血患病率约为 10%,而三分之一的儿童(12 个月至 36 个月)可能患有缺铁性贫血。此外,与贫血治疗相关的越来越多的产品批准预计将成为市场的主要贡献者。例如,最近,Pharmacosmos AS 的产品“Monoferric”获得了美国 FDA 的批准,用于治疗缺铁性贫血。因此,

Anemia Treatment Market Analysis

竞争格局

与大多数国际公司的存在相比,贫血治疗市场竞争适度。公司正专注于开发治疗贫血的药物或疗法。进入这个市场很困难,因为公司必须通过严格的规定。但是,相信未来很少有中小型公司进入市场并获得可观的份额。

主要玩家

  1. AMAG Pharmaceuticals, Inc.

  2. Sanofi

  3. Pfizer Inc.

  4. Allergan (AbbVie Inc.)

  5. PHARMACOSMOS A/S

AMAG Pharmaceuticals, Inc., Sanofi, Pfizer Inc., Allergan (AbbVie Inc.), PHARMACOSMOS A/S

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Cases of Anemia Across the Globe

      2. 4.2.2 Increasing Number of Women With Reproductive Age

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness About the Treatment in Developing Regions

      2. 4.3.2 High Cost of Drugs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Disease

      1. 5.1.1 Iron Deficiency Anemia

      2. 5.1.2 CKD (Chronic Kidney Disease) Anemia

      3. 5.1.3 Sickle Cell Anemia

      4. 5.1.4 Aplastic Anemia

      5. 5.1.5 Others

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Akebia Therapeutics

      2. 6.1.2 Bluebird Bio, Inc.

      3. 6.1.3 GlaxoSmithKline Plc.

      4. 6.1.4 Global Blood Therapeutics, Inc.

      5. 6.1.5 Pieris Pharmaceuticals, Inc.

      6. 6.1.6 Sanofi

      7. 6.1.7 Takeda Pharmaceutical Company

      8. 6.1.8 Allergan

      9. 6.1.9 Pharmacosmos A/S

      10. 6.1.10 Pfizer Inc.

      11. 6.1.11 AMAG Pharmaceuticals Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Anemia Treatment Market market is studied from 2017 - 2025.

The Anemia Treatment Market is growing at a CAGR of 7.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

AMAG Pharmaceuticals, Inc., Sanofi, Pfizer Inc., Allergan (AbbVie Inc.), PHARMACOSMOS A/S are the major companies operating in Anemia Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!